Recent Carcinoid Tumor Market Analysis by The Business Research Company, Emphasizing Upcoming Industry Trends

The Business Research Company’s Carcinoid Tumor Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /EINPresswire.com/ — “The carcinoid tumor market has been experiencing notable expansion, reflecting increasing attention toward this rare form of cancer. With advancements in treatment options and research, the market is poised for substantial growth in the coming years. Let’s explore the current market size, key factors driving this growth, dominant regions, and emerging trends shaping the industry.

Carcinoid Tumor Market Size and Growth Potential
The market for carcinoid tumors has rapidly expanded in recent years, with its value expected to rise from $1.77 billion in 2025 to $1.96 billion in 2026. This represents a compound annual growth rate (CAGR) of 10.5%. The historic growth has been driven by increased awareness about rare cancers, the establishment and expansion of oncology care centers, the availability of somatostatin analog treatments, growth of specialized cancer clinics, and progress in neuroendocrine tumor research.

Download a free sample of the carcinoid tumor market report:
https://thebusinessresearchcompany.com/sample_request?id=81571833&type=smp&name=Carcinoid%20Tumor%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Looking ahead, the carcinoid tumor market is projected to continue its strong growth trajectory, reaching $2.88 billion by 2030 with a CAGR of 10.1%. Key contributors to this forecast include the development of innovative targeted therapies, rising investments in research on rare cancers, broader application of precision oncology, growing use of personalized treatment plans, and an emphasis on improving patients’ quality of life. Notable trends anticipated include a surge in targeted neuroendocrine tumor treatments, increased use of combination drug therapies, greater focus on early diagnosis, expansion of specialized oncology centers, and strengthened long-term disease management strategies.

Understanding Carcinoid Tumors and Their Impact
Carcinoid tumors are a rare, slow-growing subset of neuroendocrine tumors often found in the gastrointestinal tract or lungs. These tumors originate from enterochromaffin cells that produce hormones like serotonin. Symptoms can vary widely depending on the tumor’s location and whether it secretes hormones, which can lead to carcinoid syndrome in some cases.

View the full carcinoid tumor market report:
https://thebusinessresearchcompany.com/report/carcinoid-tumor-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Growing Obesity Rates Fueling Market Growth
One of the primary factors expected to drive market growth is the increasing prevalence of obesity. Obesity is defined by a body mass index (BMI) of 30 or above, signifying excessive body fat accumulation. Factors like unhealthy diets, sedentary lifestyles, reduced physical activity, and higher consumption of processed and calorie-dense foods contribute to this rise. Obesity encourages carcinoid tumor development by causing chronic inflammation, insulin resistance, and heightened secretion of growth factors that promote tumor growth. For instance, data from May 2025 by the UK’s Office for Health Improvement and Disparities (OHID) revealed that around 64.5% of adults aged 18 and over in England were overweight or obese in 2023–2024, slightly higher than 64.0% in the previous year. This increasing trend in obesity is a significant driver for the carcinoid tumor market.

Additional Factors Supporting Market Expansion
Beyond obesity, other elements such as enhanced diagnostic techniques, expanded oncology infrastructure, and greater awareness about neuroendocrine tumors contribute to the market’s momentum. These factors collectively support the development and adoption of more effective treatment options, further propelling market growth.

North America Leading the Carcinoid Tumor Market
In 2025, North America held the largest share of the global carcinoid tumor market, benefiting from advanced healthcare infrastructure, extensive research activities, and high adoption of new therapies. Meanwhile, the Asia-Pacific region is forecasted to experience the fastest growth during the upcoming years. The market analysis includes regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on the carcinoid tumor landscape.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company – www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“

Oliver Guirdham
The Business Research Company
info@tbrc.info
+44 7882 955267
Visit us on social media:
LinkedIn
Facebook
X

Media gallery